<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(17)</volume><submitter>Wu YL</submitter><pubmed_abstract>Coenzyme Q10 (CoQ10), a well-known antioxidant, has been explored as a treatment in several neurodegenerative diseases, but its utility in spinocerebellar ataxia type 3 (SCA3) has not been explored. Herein, the protective effect of CoQ10 was examined using a transgenic mouse model of SCA3 onset. These results demonstrated that a diet supplemented with CoQ10 significantly improved murine locomotion, revealed by rotarod and open-field tests, compared with untreated controls. Additionally, a histological analysis showed the stratification of cerebellar layers indistinguishable from that of wild-type littermates. The increased survival of Purkinje cells was reflected by the reduced abundance of TUNEL-positive nuclei and apoptosis markers of activated p53, as well as lower levels of cleaved cas</pubmed_abstract><journal>Nutrients</journal><pagination>3593</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9459709</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Coenzyme Q10 Supplementation Increases Removal of the &lt;i>ATXN3&lt;/i> Polyglutamine Repeat, Reducing Cerebellar Degeneration and Improving Motor Dysfunction in Murine Spinocerebellar Ataxia Type 3.</pubmed_title><pmcid>PMC9459709</pmcid><pubmed_authors>Cheng WL</pubmed_authors><pubmed_authors>Huang CS</pubmed_authors><pubmed_authors>Lin YS</pubmed_authors><pubmed_authors>Yen YP</pubmed_authors><pubmed_authors>Chao YC</pubmed_authors><pubmed_authors>Liu KL</pubmed_authors><pubmed_authors>Liu CS</pubmed_authors><pubmed_authors>Liu KH</pubmed_authors><pubmed_authors>Wu YL</pubmed_authors><pubmed_authors>Sun HL</pubmed_authors><pubmed_authors>Chang JC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Coenzyme Q10 Supplementation Increases Removal of the &lt;i>ATXN3&lt;/i> Polyglutamine Repeat, Reducing Cerebellar Degeneration and Improving Motor Dysfunction in Murine Spinocerebellar Ataxia Type 3.</name><description>Coenzyme Q10 (CoQ10), a well-known antioxidant, has been explored as a treatment in several neurodegenerative diseases, but its utility in spinocerebellar ataxia type 3 (SCA3) has not been explored. Herein, the protective effect of CoQ10 was examined using a transgenic mouse model of SCA3 onset. These results demonstrated that a diet supplemented with CoQ10 significantly improved murine locomotion, revealed by rotarod and open-field tests, compared with untreated controls. Additionally, a histological analysis showed the stratification of cerebellar layers indistinguishable from that of wild-type littermates. The increased survival of Purkinje cells was reflected by the reduced abundance of TUNEL-positive nuclei and apoptosis markers of activated p53, as well as lower levels of cleaved cas</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-19T07:10:15.939Z</modification><creation>2025-04-19T07:10:15.939Z</creation></dates><accession>S-EPMC9459709</accession><cross_references><pubmed>36079853</pubmed><doi>10.3390/nu14173593</doi></cross_references></HashMap>